LE FACTEUR VII PLASMATIQUE ACTIVE EST-IL UN FACTEUR DE RISQUE CARDIOVASCULAIRE?

Translated title of the contribution: Activated factor VII in plasma: A risk factor for heart disease?

James H Morrissey

Research output: Contribution to journalShort survey

Abstract

Certain prospective epidemiologic studies (such as the Northwick Park Heart Study and the Prospective Cardiovascular Munster Study) have reported elevated factor VII coagulant activity to be an independent risk factor for heart disease. Interestingly, recent follow-up studies have indicated that factor VII coagulant activity is a much better risk predictor for fatal heart attacks than for non-fatal events. Because coagulation factor VII is the enzyme that initiates the blood clotting cascade, it is reasonable to suppose that high levels of plasma factor VII could be important in hypercoagulable states. However, this question has been controversial due to differences in methodology used to measure factor VII activity in different laboratories, and uncertainty about what is actually being measured in such assays. In particular, assays of factor VII coagulant activity measure, to varying extents, the levels of both factor VII (the inert precursor) and factor VIIa (the active enzyme) in plasma. New assay techniques based on a genetically engineered mutant of tissue factor (the protein cofactor for factor VIIa) now permit direct measurement of trace quantities of factor VIIa in plasma without interference from the large excess of factor VII. This has confirmed earlier predictions that trace amounts of pre-existing factor VIIa are a normal constituent of plasma. Currently, a number of studies are directly examining the relationship between elevated plasma factor VIIa levels and thrombotic diseases.

Original languageFrench
Pages (from-to)146-151
Number of pages6
JournalSang Thrombose Vaisseaux
Volume8
Issue number3
StatePublished - Mar 1 1996

Fingerprint

Factor VIIa
Factor VII
Heart Diseases
Prospective Studies
Thromboplastin
Blood Coagulation
Enzymes
Uncertainty
Epidemiologic Studies
Myocardial Infarction
factor VII clotting antigen
Proteins

ASJC Scopus subject areas

  • Hematology

Cite this

LE FACTEUR VII PLASMATIQUE ACTIVE EST-IL UN FACTEUR DE RISQUE CARDIOVASCULAIRE? / Morrissey, James H.

In: Sang Thrombose Vaisseaux, Vol. 8, No. 3, 01.03.1996, p. 146-151.

Research output: Contribution to journalShort survey

@article{856e9bbbe6bc4425990303347fae5060,
title = "LE FACTEUR VII PLASMATIQUE ACTIVE EST-IL UN FACTEUR DE RISQUE CARDIOVASCULAIRE?",
abstract = "Certain prospective epidemiologic studies (such as the Northwick Park Heart Study and the Prospective Cardiovascular Munster Study) have reported elevated factor VII coagulant activity to be an independent risk factor for heart disease. Interestingly, recent follow-up studies have indicated that factor VII coagulant activity is a much better risk predictor for fatal heart attacks than for non-fatal events. Because coagulation factor VII is the enzyme that initiates the blood clotting cascade, it is reasonable to suppose that high levels of plasma factor VII could be important in hypercoagulable states. However, this question has been controversial due to differences in methodology used to measure factor VII activity in different laboratories, and uncertainty about what is actually being measured in such assays. In particular, assays of factor VII coagulant activity measure, to varying extents, the levels of both factor VII (the inert precursor) and factor VIIa (the active enzyme) in plasma. New assay techniques based on a genetically engineered mutant of tissue factor (the protein cofactor for factor VIIa) now permit direct measurement of trace quantities of factor VIIa in plasma without interference from the large excess of factor VII. This has confirmed earlier predictions that trace amounts of pre-existing factor VIIa are a normal constituent of plasma. Currently, a number of studies are directly examining the relationship between elevated plasma factor VIIa levels and thrombotic diseases.",
author = "Morrissey, {James H}",
year = "1996",
month = "3",
day = "1",
language = "French",
volume = "8",
pages = "146--151",
journal = "Sang Thrombose Vaisseaux",
issn = "0999-7385",
publisher = "John Libbey Eurotext",
number = "3",

}

TY - JOUR

T1 - LE FACTEUR VII PLASMATIQUE ACTIVE EST-IL UN FACTEUR DE RISQUE CARDIOVASCULAIRE?

AU - Morrissey, James H

PY - 1996/3/1

Y1 - 1996/3/1

N2 - Certain prospective epidemiologic studies (such as the Northwick Park Heart Study and the Prospective Cardiovascular Munster Study) have reported elevated factor VII coagulant activity to be an independent risk factor for heart disease. Interestingly, recent follow-up studies have indicated that factor VII coagulant activity is a much better risk predictor for fatal heart attacks than for non-fatal events. Because coagulation factor VII is the enzyme that initiates the blood clotting cascade, it is reasonable to suppose that high levels of plasma factor VII could be important in hypercoagulable states. However, this question has been controversial due to differences in methodology used to measure factor VII activity in different laboratories, and uncertainty about what is actually being measured in such assays. In particular, assays of factor VII coagulant activity measure, to varying extents, the levels of both factor VII (the inert precursor) and factor VIIa (the active enzyme) in plasma. New assay techniques based on a genetically engineered mutant of tissue factor (the protein cofactor for factor VIIa) now permit direct measurement of trace quantities of factor VIIa in plasma without interference from the large excess of factor VII. This has confirmed earlier predictions that trace amounts of pre-existing factor VIIa are a normal constituent of plasma. Currently, a number of studies are directly examining the relationship between elevated plasma factor VIIa levels and thrombotic diseases.

AB - Certain prospective epidemiologic studies (such as the Northwick Park Heart Study and the Prospective Cardiovascular Munster Study) have reported elevated factor VII coagulant activity to be an independent risk factor for heart disease. Interestingly, recent follow-up studies have indicated that factor VII coagulant activity is a much better risk predictor for fatal heart attacks than for non-fatal events. Because coagulation factor VII is the enzyme that initiates the blood clotting cascade, it is reasonable to suppose that high levels of plasma factor VII could be important in hypercoagulable states. However, this question has been controversial due to differences in methodology used to measure factor VII activity in different laboratories, and uncertainty about what is actually being measured in such assays. In particular, assays of factor VII coagulant activity measure, to varying extents, the levels of both factor VII (the inert precursor) and factor VIIa (the active enzyme) in plasma. New assay techniques based on a genetically engineered mutant of tissue factor (the protein cofactor for factor VIIa) now permit direct measurement of trace quantities of factor VIIa in plasma without interference from the large excess of factor VII. This has confirmed earlier predictions that trace amounts of pre-existing factor VIIa are a normal constituent of plasma. Currently, a number of studies are directly examining the relationship between elevated plasma factor VIIa levels and thrombotic diseases.

UR - http://www.scopus.com/inward/record.url?scp=0029879669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029879669&partnerID=8YFLogxK

M3 - Short survey

AN - SCOPUS:0029879669

VL - 8

SP - 146

EP - 151

JO - Sang Thrombose Vaisseaux

JF - Sang Thrombose Vaisseaux

SN - 0999-7385

IS - 3

ER -